Viewing Study NCT00053833


Ignite Creation Date: 2025-12-25 @ 2:48 AM
Ignite Modification Date: 2025-12-31 @ 12:56 PM
Study NCT ID: NCT00053833
Status: TERMINATED
Last Update Posted: 2013-11-08
First Post: 2003-02-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: S0025 Irinotecan in Treating Patients With Refractory Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
Sponsor: SWOG Cancer Research Network
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module